LAUSR

Key Points Question Is intensive blood pressure management among older patients with hypertension cost-effective? Findings This economic evaluation with a Markov model and extensive sensitivity analyses estimated the incremental lifetime medical costs, quality-adjusted life-years (QALYs), and cost-effectiveness of intensive vs standard blood pressure targets for older patients with hypertension in China, the US, and the UK. Intensive blood pressure control produced fewer cardiovascular events and low costs per QALY gained, well below the typical willingness-to-pay thresholds, and the cost-effective advantages were consistent over various clinical scenarios across different countries. Meaning These clinical and economic findings suggest intensive blood pressure control is cost-effective in older adults.